Announcements Trials

Browse Landscape

Phase

Phase NA 24 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 59 Neoplasms 23 Prostatic Neoplasms 21 Multiple Myeloma 18 Carcinoma, Hepatocellular 15 Carcinoma, Non-Small-Cell Lung 14 Stomach Neoplasms 11 Papillomavirus Infections 11 Lung Neoplasms 11 Colorectal Neoplasms 10 Melanoma 9 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Waldenstrom Macroglobulinemia 6 Pain, Postoperative 6 Lymphoma, Non-Hodgkin 6 Leiomyoma 6 Hematologic Neoplasms 6 Brain Neoplasms 6 Thyroid Neoplasms 5 Smoking Cessation 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Polycystic Ovary Syndrome 5 Lymphoma 5 Glioma 5 Carcinoma, Renal Cell 5 Venous Thromboembolism 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Tobacco Use Disorder 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Behavior × 1 year × Clear all

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡